MENU
TMED
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

TMED stock forecast, quote, news & analysis

The investment seeks long-term capital appreciation... Show more

Category: #Health
TMED
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for TMED with price predictions
Sep 11, 2026

TMED in downward trend: price dove below 50-day moving average on September 08, 2026

TMED moved below its 50-day moving average on September 08, 2026 date and that indicates a change from an upward trend to a downward trend. In 4 of 4 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TMED as a result. In 13 of 17 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.

The Moving Average Convergence Divergence Histogram (MACD) for TMED turned negative on August 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 15 similar instances when the indicator turned negative. In 13 of the 15 cases the stock turned lower in the days that followed. This puts the odds of success at 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMED declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +4.32% 3-day Advance, the price is estimated to grow further. Considering data from situations where TMED advanced for three days, in 59 of 64 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

TMED may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 61 of 67 cases where TMED Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Gilead Sciences (NASDAQ:GILD), Elanco Animal Health (NYSE:ELAN).

Industry description

The investment seeks long-term capital appreciation. The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of health care companies. The manager defines health care companies as companies engaged in health care innovations, such as developing new and effective therapies; pharmaceuticals; biotechnology; life sciences tools and services; managed health care; and/or health care equipment, supplies, providers, services, distributors, and facilities. The fund is non-diversified.

Market Cap

The average market capitalization across the T. Rowe Price Health Care ETF ETF is 165.79B. The market cap for tickers in the group ranges from 9.15B to 994.49B. LLY holds the highest valuation in this group at 994.49B. The lowest valued company is PODD at 9.15B.

High and low price notable news

The average weekly price growth across all stocks in the T. Rowe Price Health Care ETF ETF was -5%. For the same ETF, the average monthly price growth was -5%, and the average quarterly price growth was 18%. CYTK experienced the highest price growth at 1%, while PODD experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the T. Rowe Price Health Care ETF ETF was 24%. For the same stocks of the ETF, the average monthly volume growth was -0% and the average quarterly volume growth was -2%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 42
P/E Growth Rating: 57
Price Growth Rating: 50
SMR Rating: 58
Profit Risk Rating: 74
Seasonality Score: -19 (-100 ... +100)
View a ticker or compare two or three
TMED
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
100 EAST PRATT STREETBALTIMORE MD 21202
Phone
410-345-2000
Web
N/A
TMED in downward trend: price dove below 50-day moving average on September 08, 2026